Monetary gain and high-risk tactics stimulate activity in the brain
Milan, Italy, 17 November 2009 - Monetary gain stimulates activity in the brain. Even the mere possibility of receiving a reward is known to activate an area of the brain called the striatum. A team of Japanese researchers report in the January 2010 issue of Cortex, published by Elsevier, the results of a study in which they measured striatum activation in volunteers performing a monetary task and found high-risk/high-gain options to cause higher levels of activation than more conservative options. They also found levels of activation to increase with the amount of money owned.
Dr. Tadashi Ino and colleagues, from the Department of Neurology at the Rakuwakai-Otowa Hospital and the Research Center for Nano Medical Engineering at Kyoto University, used functional magnetic resonance imaging (fMRI) to study hemodynamic changes in the brains of 17 healthy volunteers performing a monetary task. The volunteers were given an initial stock of money and then required repetitively to press one of two buttons, which resulted in either an increase or decrease of the money stock, depending on whether their choice agreed or disagreed with a number that appeared randomly after the button had been pressed. One button was a low-risk option and the other involved high-risk, so that more money was gained or lost when choosing the high-risk option. The volunteers were also able to keep track of the total money stock throughout the task.
They found higher levels of activation in volunteers when choosing high-risk/high-gain options, compared to low-risk/low-gain, and when gaining money, compared to losing money. It did not matter how much money was gained, since small gains stimulated the volunteers’ striatum as much as large gains. They also found that overall striatum activity increased with the total amount of money in stock.
According to the authors, these results show that “risky tactics and pleasure of monetary gain are correlated with activation of the striatum” and that this finding demonstrates “the concept of the striatum as a major reward-related brain structure”.
# # #
Notes to Editors:
The article is “Differential activation of the striatum for decision making and outcomes in a monetary task with gain and loss” by Tadashi Ino, Ryusuke Nakai, Takashi Azuma, Toru Kimura and Hidenao Fukuyama and appears in Cortex, Volume 46, Issue 1 (January 2010), published by Elsevier in Italy. Full text of the article featured above is available to members of the media upon request. Please contact the Elsevier press office, firstname.lastname@example.org. To schedule an interview, contact Dr. Tadashi Ino, email@example.com.
Cortex is an international journal devoted to the study of cognition and of the relationship between the nervous system and mental processes, particularly as these are reflected in the behaviour of patients with acquired brain lesions, normal volunteers, children with typical and atypical development, and in the activation of brain regions and systems as recorded by functional neuroimaging techniques. It was founded in 1964 by Ennio De Renzi. The Editor in-chief of Cortex is Sergio Della Sala, Professor of Human Cognitive Neuroscience at the University of Edinburgh. Fax: 0131 6513230, e-mail: firstname.lastname@example.org. Cortex is available online at http://www.sciencedirect.com/science/journal/00109452
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+39 02 88184 260